China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Predicting Myelosuppression Risk after Chemotherapy in Gynecological Cancer Patients'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131862
Registration Time: 2026/09/07
Type: Observational study
Primary Sponsor: Peking Union Medical College Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341599
Published by HT Digital Content Services with permission from Health Daily Digest....